Navigation Links
Looking to Lose Weight?
Date:8/9/2012

SHREWSBURY, MA A new study published in Nutrition Journal shows that people can lose weight while consuming typical amounts of sugar or high fructose corn syrup (HFCS) if their overall caloric intake is reduced.

"Our research debunks the vilification of high fructose corn syrup in the diet," said James M. Rippe, M.D., one of the study authors. "The results show that equally reduced-calorie diets caused similar weight loss regardless of the type or amount of added sugars. This lends further support to findings by our research group and others that table sugar and HFCS are metabolically equivalent."

The results are significant for those trying to lose weight and anyone concerned about the type of added sugars in foods and beverages they consume. Importantly, this study looks at sweeteners consumed in real-world diets and at levels that are typical among American consumers.

"We wanted to design a study that would generate information that is useful and applicable to the way people actually eat, not speculative results on simulated laboratory diets that focus on one component at extreme dietary levels," explained Dr. Rippe.

The study design included 247 overweight or obese subjects ages 25 to 60 who took part in the randomized, double blind trial. After 12 weeks on a hypocaloric (reduced calorie) diet, there was no evidence that either table sugar or HFCS prevented weight loss when the amount of overall calories was reduced.

"Misinformation about added sugars, particularly high fructose corn syrup, has caused many people to lose sight of the fact that there is no silver bullet when it comes to weight loss," said Dr. Rippe. "A reduction in calorie consumption, along with exercise and a balanced diet, is what's most important when it comes to weight loss."


'/>"/>
Contact: Carol Moreau
cmoreau@rippelifestyle.com
508-756-1228
Fleishman-Hillard, Inc.
Source:Eurekalert

Page: 1

Related medicine news :

1. Why do older adults display more positive emotion? It might have to do with what they’re looking at
2. Scientists looking for noninvasive ways to detect lung cancer early
3. Want to lose weight? Keep a food journal, dont skip meals and avoid going out to lunch
4. Can Testosterone Therapy Help Obese Men Lose Weight?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... The Wharton School’s Aresty Institute ... as a kick-off to the fifth annual CEO Connection Mid-Market Convention. , ... of Pennsylvania campus, followed by the two-day convention, which will target C-suite executives ...
(Date:6/28/2017)... Santa Clara, CA (PRWEB) , ... June 28, 2017 , ... ... is hosting a free AFM Luncheon for all SEMICONWest attendees and Park ... The luncheon will feature talks from Dr. Sang-il Park, Chairman & CEO of Park ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... and financial planning assistance to clients in southern Montana, is announcing a focused ... Zoo Montana. , The outreach programs offered by Zoo Montana provide students with ...
(Date:6/28/2017)... ... June 28, 2017 , ... Designers Insurance Agency, a ... northern Virginia and DC, is announcing a cooperative charity event in conjunction with ... other disorders that lead to memory impairment. , The Insight Memory Care Center ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... ... announced the appointment of Mike Finnegan to the position of Executive Vice President, ... of experience in healthcare technology, telehealth and medical device sales leadership. He has ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... , June 13, 2017 Zimmer Biomet Holdings, ... healthcare, today announced that the U.S. Food and Drug Administration ... June 3, 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning ... manufacturing facility is a measure of the progress we ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
Breaking Medicine Technology: